NR2C2AP, which was highly expressed in NSCLC, also known as TRA16, could promote cancer cell growth by enhancing the ERβ signaling pathway and was associated with lymph node metastasis and poor OS (Fang et al., 2013). Here, NR2C2AP is linked to cancer.